Survival after ABO-mismatch living donor liver transplant for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial looks at how well patients with liver cancer do after receiving a living donor liver transplant that is not the same blood type. It compares survival and cancer return for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- Had a living donor liver transplant for liver cancer
- Transplant happened between January 2012 and December 2023
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines medical records from patients who received a liver transplant for hepatocellular carcinoma (a type of liver cancer) between 2018 and 2023. The goal is to understand treatment outcomes and improve care for future patients.
This trial tests whether a liver transplant from a living donor can help people with a certain bile duct cancer that hasn't spread. It is for patients whose cancer is stable or smaller after chemotherapy.
This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.
This study tests a special way of preserving donated livers, called HOPE, to see if it lowers the chance of liver cancer coming back after a liver transplant. If you have liver cancer and are waiting for a transplant, this trial might be an option for you.
This study looks at two blood markers (AFP and PIVKA-II) to see if they can help predict outcomes for people getting a liver transplant for liver cancer. It aims to find better ways to guide care after transplant.
This study looks at the results of liver transplants from living donors with a different blood type than the recipient. It aims to understand how well patients do after this type of transplant.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.